Harrison Dermatology

Harrison Dermatology, also known as Harrison Dermatology & Research Group, is a specialized medical practice and clinical research center based in Missouri City, Texas. Led by Dr. Harrison Nguyen, the organization provides comprehensive medical, surgical, and cosmetic dermatological care, with a particular focus on Mohs micrographic surgery and advanced skin cancer treatment. Beyond clinical care, the group operates as a significant clinical research site, partnering with major pharmaceutical companies like Novartis and Leo Pharma to conduct Phase 2 and Phase 3 clinical trials for conditions such as atopic dermatitis, psoriasis, and chronic urticaria. The practice integrates cutting-edge diagnostic tools, such as Castle Biosciences' genomic tests, into its clinical workflow to improve patient outcomes in melanoma and other skin diseases.